insights_auto
Why is EDIT up 8.33%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
$2.60
arrow_upward
+8.33%(+0.20) 1D
$2.58
arrow_downward
-0.77% (-0.020)todayPre-market
Closed: Oct 27, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
$2.41
High
$2.61
Low
$2.37
Mkt. cap
399.31M
Avg. vol.
2.87M
Volume
453.00
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.00
Shares outstanding
153.58M
No. of employees
87
Open
$2.41
High
$2.61
Low
$2.37
Mkt. cap
399.31M
Avg. vol.
2.87M
Volume
453.00
52-wk high
$3.94
52-wk low
$1.66
EPS
-$0.74
Beta
2.00
Shares outstanding
153.58M
No. of employees
87
News stories
From web sources and news partners
Business Chief
·
14 hours ago
The S&P 493: Where the AI Boom’s Money Never Arrived
investingLive
·
16 hours ago
The S&P and Nasdaq 100 are trying to tilt the bias to the upside technically
KuCoin
·
8 hours ago
Fed decision this Wednesday. Here’s why the first market
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company which is developing therapies for rare diseases based on CRISPR gene editing technology. Editas headquarters is located in Cambridge, Massachusetts and has facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc